Harrow, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Harrow, Inc. (HROW) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 13.13 thousand shares for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-06.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2013-11-06
- Harrow, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2013-03-31 was -15.25K shares.
- Harrow, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2012-12-31 was 575.00K shares.
- Harrow, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2012-09-30 was -93.75K shares.
- Harrow, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2012 was -143.75K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2013-09-30 | 13.13K shares 10-Q · filed 2013-11-06 | |||
| 2013-03-31 | -15.25K shares 10-Q · filed 2013-05-08 | 559.75K shares derived: sum of 2 quarters · filed 2013-05-08 | 466.00K shares derived: sum of 3 quarters · filed 2013-05-08 | |
| 2012-12-31 | 575.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | 481.25K shares derived: sum of 2 quarters · filed 2013-03-18 | -143.75K shares 10-K · filed 2013-03-18 | |
| 2012-09-30 | -93.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -718.75K shares 10-Q · filed 2012-11-14 | ||
| 2012-06-30 | -625.00K shares 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |